Ronald G Crystal
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$2.9MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 13, 2026 | NIH | STTR Phase II Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency in Post-menopausal East Asian Women | $792K | ENYX THERAPEUTICS LLC |
| Aug 27, 2025 | NIH | STTR Phase II Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency in Post-menopausal East Asian Women | $1.3M | ENYX THERAPEUTICS LLC |
| Apr 25, 2024 | NIH | STTR Phase I Gene Therapy-mediated Angiogenesis to Enhance Survival of Transplanted Fat | $296K | ENYX THERAPEUTICS LLC |
| Mar 15, 2024 | NIH | STTR Phase I Safety of AAV-mediated C1 Esterase Inhibitor Gene Therapy for Hereditary Angioedema | $276K | ENYX THERAPEUTICS LLC |
| May 5, 2022 | NIH | STTR Phase I Anti-eosinophil Gene Therapy for Eosinophilic Esophagitis | $300K | ENYX THERAPEUTICS LLC |
Peer ranks
Federal funding#645
Awards as PI#417
Patents#273
Companies
- ENYX THERAPEUTICS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.